1. Introduction {#sec1-biomolecules-10-00597}
===============

The new concept of healthy food is boosting the use of natural compounds as alternatives to chemical preservatives in preventing bacterial deterioration \[[@B1-biomolecules-10-00597]\]. Bio-preservation exploit non-pathogenic microorganisms and their metabolites having antimicrobial effect \[[@B2-biomolecules-10-00597]\]; in this frame, bacteriocins can be good candidate compounds as long as they lack toxic effects to humans \[[@B3-biomolecules-10-00597],[@B4-biomolecules-10-00597]\]. Chemically, bacteriocins are small proteins or peptides, heat-stable, active at acidic pH and, owing to the low concentrations required, do not modify food flavour \[[@B3-biomolecules-10-00597],[@B5-biomolecules-10-00597]\]. Numerous classifications have been proposed based on their structure, mode of action, biochemical properties and post-translational odifications \[[@B6-biomolecules-10-00597]\], nevertheless, class I and II bacteriocins are the most studied. Their targets are mainly foodborne pathogens such as *Listeria monocytogenes*, *Staphylococcus aureus*, *Escherichia coli* and *Salmonella* spp. \[[@B5-biomolecules-10-00597]\]. The main obstacle to widespread use of bacteriocins in food biopreservation is the high price of their commercial preparations due to the low fermentation yields and high production costs. Complex growth media are needed, which often cannot be classified as food-grade. The MRS (de Man, Rogosa and Sharpe) medium is currently considered as the most suitable for promoting the growth of lactic acid bacteria (LAB). However, it is expensive and thus its use for industrial production of bacteriocins appears unfeasible. An attractive approach to producing food-grade bacteriocins is to use by-products of the agro-food industry in the formulation of culture media \[[@B3-biomolecules-10-00597]\]. In this frame, cheese whey (CW) and whey fermentations by LAB.

CW is obtained as a by-product of cheese manufacture. It represents around 90% of the initial milk volume and contains soluble components, including lactose, whey proteins, peptides and amino acids, minerals and water-soluble vitamins. Owing to their distinctive nutritional and functional characteristics, whey proteins are mainly recovered from CW by ultrafiltration (UF) and become ingredients for a variety of foods, pharmaceuticals and cosmetics \[[@B7-biomolecules-10-00597]\]. The UF process generates a further by-product, namely cheese whey permeate (CWP), that is highly perishable, has high disposal costs and serious environmental impact \[[@B8-biomolecules-10-00597],[@B9-biomolecules-10-00597]\], but at the same time, it retains valuable milk components \[[@B10-biomolecules-10-00597]\]. Liquid CWP is partly destined to lactose production, but most is turned into powder \[[@B9-biomolecules-10-00597]\]. As a consequence of an expected increase in demand for whey protein concentrates, the availability of CWP will grow as well \[[@B11-biomolecules-10-00597],[@B12-biomolecules-10-00597],[@B13-biomolecules-10-00597]\], which may represent a resource for activating valuable circular economy activities \[[@B14-biomolecules-10-00597]\]. World CWP volume (in powder) is estimated in 855,000 Metric Tonnes (MT) in 2017, with an expected increase by 4% Compound Annual Growth Rate (CAGR) over the period 2017--2027 \[[@B15-biomolecules-10-00597]\]. The associated market value of world CWP production is worth in 598 Millions of Euro in 2017. Market price for CWP powder was 0.7 €/kg in 2017 and is expected to increase up to 0.731 €/kg in 2027. Note that these data refer to CWP powder cost, that incorporates the drying step; transformation in powder is performed to make CWP transportable and storable. According to various experts' opinion, the price of liquid unprocessed CWP is in the range 1--1.5 cent €/L, including the refrigeration costs.

Therefore, using liquid or powder CWP depends on logistic evaluations, based on the proximity between UF plants and the place in which CWP is used for circular bioeconomy activities. The conversion of dairy industry effluents from waste to resources, with different options of management and valorisation, has a long stand history \[[@B16-biomolecules-10-00597],[@B17-biomolecules-10-00597]\]. However, the increasing societal demand for more sustainable food manufacture processes has boosted the research in this field.

In particular, the use of CWP has been experimented as a substrate to obtain bioproducts having different degrees of added value, such as lactic acid \[[@B18-biomolecules-10-00597]\], biopolimers \[[@B19-biomolecules-10-00597]\], biofuel and biogas \[[@B20-biomolecules-10-00597],[@B21-biomolecules-10-00597]\] as well as microalgae \[[@B22-biomolecules-10-00597]\].

*Listeria monocytogenes* is a Gram-positive, facultative anaerobe, motile, non-spore forming, rod shaped bacterium that has been known as the causative agent of listeriosis, a highly fatal opportunistic foodborne infection. Listeriosis is rare, but its social and economic impact is one of the highest among foodborne diseases \[[@B23-biomolecules-10-00597]\]. Sakacin A, a bacteriocin produced by *Lactobacillus sakei*, as all class IIa bacteriocins, primarily acts by permeabilizing *Listeria* membrane, dissipating (in term of seconds) transmembrane potential (ΔΨ) and pH gradient (ΔpH) through the formation of pores \[[@B6-biomolecules-10-00597]\]. Other sakacins have been identified and characterized from a variety of *L. sakei* strains, most of which isolated from raw meat. Examples are sakacin M, P, 674, B and K \[[@B24-biomolecules-10-00597]\]. Sakacin A presents a 100% sequence identity with the bacteriocin produced from *Lactobacillus curvatus*, curvacin A. Although these two proteins could be considered equivalent under a molecular point of view, small differences are reported in the gene cluster organization \[[@B25-biomolecules-10-00597]\]. Recently, it has been highlighted that sakacin A can find application in preserving food items potentially contaminated with *Listeria monocytogenes*, such as ready-to-eat products, with the bacteriocin successfully incorporated in food packaging material \[[@B26-biomolecules-10-00597],[@B27-biomolecules-10-00597],[@B28-biomolecules-10-00597]\]. It is worth noting that the market value of the antimicrobial packaging sector is currently 29.0 billion US\$ \[[@B29-biomolecules-10-00597],[@B30-biomolecules-10-00597]\], supporting the interests of the food industry in this new technology. Economic feasibility of this approach, however, strongly lies in market availability of food-grade bacteriocins at relatively low cost.

The aim of the present study was to develop a novel and cheap CWP-based food-grade culture medium for *L. sakei* to produce sakacin A. Growth conditions of the strain, nutrient supplementation and bacteriocin yield were optimized. Liquid CWP was used as the basic ingredient in view of establishing a bioprocess that can be easily scaled up, avoiding CWP concentration and drying costs.

2. Materials and Methods {#sec2-biomolecules-10-00597}
========================

2.1. Microorganisms and Maintenance {#sec2dot1-biomolecules-10-00597}
-----------------------------------

*Lactobacillus sakei* DSMZ 6333 (Lb706) (DSMZ: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany) was the sakacin-A-producing strain while *Listeria innocua* DSMZ 20649 was the target strain. The two strains were maintained on MRS broth (DeMan-Rogosa-Sharpe, Merck K GaA, Darmstadt, Germany) and on TSB (Tryptic Soy Broth; Merck K GaA) inoculating media (10% *v*/*v*) respectively. A pre-grown culturing and incubation in stationary condition for 16 h were carried out at 30 °C for *L. sakei* and 37 °C for *L. innocua*. Stock cultures of both microorganisms were stored at −80 °C in the medium added with 20% (*v*/*v*) glycerol (VWR International, Leuven, Belgium). Cultures were propagated twice before use.

2.2. Quantification of Sakacin a Activity {#sec2dot2-biomolecules-10-00597}
-----------------------------------------

Antimicrobial activity of sakacin A was evaluated by the agar diffusion assay, as reported in Mapelli et al. \[[@B29-biomolecules-10-00597]\]. Briefly, aliquots of overnight *Listeria* culture were added to soft TSA (TSB added with 8 g/L agar) in a Petri dish, then cell-free supernatant of *L. sakei* culture was properly diluted and poured in wells previously made on the plate. Plates were incubated overnight at 37 °C and sakacin A production was quantified as Activity Units per medium (AU/mL) according to Trinetta et al. \[[@B30-biomolecules-10-00597]\] or, alternatively, as the measure (mm) of inhibition halo around the wells.

2.3. Lactobacillus Sakei Growth Evaluation {#sec2dot3-biomolecules-10-00597}
------------------------------------------

A culture medium for *L. sakei* (SAK-medium) was initially used, having the following composition: meat extract, ME (VWR) 8 g/L; yeast extract, YE (Costantino srl, Turin, Italy) 8 g/L; arginine, ARG (Merck K GaA) 0.5 g/L; Tween-80 (Merck K GaA) 0.5 mL/L, minerals and vitamins mix 1 mL/L as reported by Mapelli et al. \[[@B27-biomolecules-10-00597]\]. Ingredients were dissolved in liquid CWP, kindly supplied by Latteria Soresina (Soresina, Italy).

Freshly produced CWP was collected at the cheese factory from the UF plant that processes whey from hard cheese manufacture, immediately frozen and kept at −20 °C until use. The CWP batch had a lactose content of 42 g/L and pH 6.2 and was filter sterilized just before use.

Both *L. sakei* growth and sakacin A production were determined in the SAK-medium and in MRS, being the latter taken as benchmark. *L. sakei* growth was studied at 26°C with different percentage of inoculum, i.e., 0.1, 0.5, 1 and 5% (*v*/*v*). Culture turbidity (OD) was measured spectrophotometrically at 600 nm every 15 min in a PowerWave™ XS2 Microplate Spectrophotometer (BioTek, Winooski, VT, USA); lag phase (min) and maximum growth rate (OD/h) were determined fitting data through the Baranyi and Roberts model \[[@B31-biomolecules-10-00597]\] on DMFit 3.5 Excel add-in.

2.4. Sakacin-A Production and Process Optimization {#sec2dot4-biomolecules-10-00597}
--------------------------------------------------

A general full factorial design with 3 variables was set-up to identify components and/or interactions having significant effect on sakacin A production; the chosen levels were as follows: A-ME 0--4--8 g/L; B-YE 0--4--8 g/L; C-ARG 0--0.5--1 g/L; these concentrations were chosen in order to maximize production of sakacin A while possibly reducing the cost of the culture medium. The 27 combinations were tested in duplicate, giving rise to a total of 54 trials. Culture formulations were all inoculated with a pre-grown *L. sakei* liquid culture and incubated at 26 °C to promote bacteriocin production.

Multiple factors interactions were determined employing Design Expert^®^ v. 12.0 software (Stat-Ease Inc., Minneapolis, MN, USA), combined with the Student t test to evaluate whether given terms had significant effect (*p* ≤ 0.05). Results were monitored in terms of pH value, measured with a pH-meter (FiveEasy™, Mettler Toledo, Schwerzenbach, Swiss), lactic acid production, amino acid consumption, as well as bacteriocin production, measured in terms of diameter (mm) of the inhibition halo. Quality of fitted model equations was expressed by the regression coefficient R-square. Statistical parameters and interactions significance were verified by the analysis of variance (ANOVA). Parametric estimations, calculated from the results, were carried out by minimizing the sum of quadratic differences between observed and model-predicted values, using the non-linear least-squares procedure.

2.5. Lactic Acid and Amino Acids Determinations {#sec2dot5-biomolecules-10-00597}
-----------------------------------------------

Lactic acid was determined in the culture media after centrifugation and filtration of the supernatant. An HPLC system (Merck-Hitachi L-7000 System) was used, equipped with an UV detector (210 nm), using a (300 × 8 mm) SH1821 column (Shodex, München, Germany), maintained at 50 °C and eluted with 5 mM H~2~SO~4~ at 0.5 mL/min.

Free amino acids, including added arginine, were analysed in culture sample supernatants that were further adjusted to pH 2.2 and filtered. A Biochrom 30+ automatic amino acid analyser (Biochrom Ltd., Cambridge, UK) was used and elution conditions recommended by the manufacturer were adopted. A 14-step elution program with six lithium citrate buffers of increasing pH and ionic strength was adopted, with post-column derivatization with ninhydrin and detection at 440 and 570 nm. Five-level calibration curves were used for amino acid quantification \[[@B32-biomolecules-10-00597]\].

3. Results and Discussion {#sec3-biomolecules-10-00597}
=========================

3.1. L. Sakei Growth and Sakacin a Production in MRS and SAK Media {#sec3dot1-biomolecules-10-00597}
------------------------------------------------------------------

The optimized process for sakacin A production, using CWP as a substrate, refers to a lab-scale cost minimization consideration. Process optimization, based on lab-scale cost minimization, may present some limitations. First, lab-scale production costs include only the cost of ingredients for medium formulation. Given the small production scale, energy, labor and fixed costs associated with lab facilities, are not included in the computation. Such omitted costs, may lead to an increase in the total costs when production is up-scaled from lab-level to pilot- and plant-level. On the other hand, up scaling the production usually brings to a decrease in average cost of production, for the well-known phenomenon of economies of scale. Such relationship is due to both, technological and market reasons. The technological reasons are explained by the increasing return to scale: an increase of 1% in production inputs (labour, ingredients and machinery/plants) brings to a production increase bigger than 1%. Market reasons that contributes to economies of scale, relate to the decreasing procurement costs of variable inputs: Growth of production increases the demand of ingredients for the medium, which in turn reduces their buying price for the plant. All the above mentioned explanations point out that lab-scale production costs are not necessarily a good forecast of plant-level production costs, even if, usually, the former are higher of the latter. Another limitation of optimization, based on lab-scale production costs, is the comparability across processes in different market conditions. The production cost is computed by multiplying the quantity of each ingredient used in 1 L of medium, per unit cost (price). For this reason, production cost of processes presented in this paper are comparable among them and with other process of production of sakacin A only under the assumption of equal price (per-unit cost) of the ingredients used in the medium. Nevertheless, to ensure comparability among production processes in this paper and from other authors, we provide the composition of each medium/formulation, so that, for each process, the production cost can be recomputed based on different market prices of each ingredient.

The initial formulation of SAK-medium, the prices of all ingredients used in the present analysis as well as that of MRS, taken on the basis of their cost at lab scale, are shown in [Table 1](#biomolecules-10-00597-t001){ref-type="table"}. Meat extract (ME), yeast extract (YE) and Tween 80 are also present in MRS, the first two to support microbial growth, while Tween 80 reduces the mean particle size and polydispersity index of ingredients, thus, allowing a fastest microbial uptake \[[@B33-biomolecules-10-00597]\]. All minerals present in MRS (sodium acetate, MgSO~4~, MnSO~4~, ammonium citrate, potassium phosphate) were avoided and replaced by those naturally present in CWP. The initial concentration of ME, YE and the other ingredients, dissolved in CWP, have been chosen on the basis of previously published data \[[@B26-biomolecules-10-00597],[@B27-biomolecules-10-00597]\]. The presence of arginine was evaluated to investigate the possibility of promoting the arginine deiminase (ADI) pathway, adopted by a variety of bacterial species for obtaining further ATP for cell growth and NH~3~ that helps in maintaining the pH to physiological levels. The enzymes involved in the ADI pathway catalyze the conversion of arginine to citrulline, NH~3~ and CO~2~, while generating ATP. Citrulline can be further metabolized into ornithine and carbamoyl-phosphate \[[@B34-biomolecules-10-00597]\].

Based on this composition, the SAK-medium was cheaper (−58%) than MRS, i.e., 2.30 and 5.40 €/L, respectively. Furthermore, the cost share of CWP on total cost of SAK was the lowest among ingredients, confirming CWP as a potential cheap substrate.

*L. sakei* growth was monitored comparatively in SAK and MRS media differently inoculated (0.1--0.5--1--5% *v*/*v*) ([Figure 1](#biomolecules-10-00597-f001){ref-type="fig"}). Analyses of the fitted growth curves identified *L. sakei* lag phase (h), growth rate (OD/h) and final OD value ([Table 2](#biomolecules-10-00597-t002){ref-type="table"}).

As expected, the lag phase significantly decreased with the increase of inoculum percentage for both media and, regardless to the inoculum, longer in SAK. Even if slightly higher *L. sakei* growth (final OD) was obtained in MRS, growth rates were always higher in SAK, highlighting that the formulation containing CWP can effectively support *L. sakei* growth. The quantification of the antimicrobial activity confirmed that the highest sakacin A production was reached at the end of the exponential phase of each curve \[[@B27-biomolecules-10-00597],[@B35-biomolecules-10-00597]\], i.e., at 8 h for cultures inoculated at 5% (*v*/*v*) (300 and 333 AU/mL in MRS and SAK respectively) and 16 h for 0.1--0.5% (*v*/*v*) (233--267 AU/mL).

3.2. Optimization of SAK Medium Formulation {#sec3dot2-biomolecules-10-00597}
-------------------------------------------

Different formulations of the initial SAK medium were tested with the possibility of reducing their amount, in order to further reduce sakacin A production costs. Ingredients were evaluated for their influence on pH decrease, lactic acid and sakacin A production ([Table 3](#biomolecules-10-00597-t003){ref-type="table"}). As previously explained, pH time course cannot be considered totally representative of sakacin A production due to the possible activation of the ADI pathway with consequent NH~3~ production. On the contrary, as lactic acid production is directly linked to bacterial growth, its concentration can be correlated to the presence of sakacin A \[[@B27-biomolecules-10-00597]\]; concentrations of lactic acid higher than 2 g/L were found when YE concentration was set at its maximum level and above all when in presence of ME, while arginine seems not to be correlated with microbial growth and lactic acid production.

ANOVA analyses identified as significant positive terms A-ME, B-YE and the combination AB ([Table 4](#biomolecules-10-00597-t004){ref-type="table"}); as expected, in pH responses as expected the term C-Arg and the interactions AC and BC were found significant; as for sakacin A production, all the terms and interactions resulted significant. Model adaptation goodness, variability and noise ratio were found adequate for all the three models identified by the software. [Figure 2](#biomolecules-10-00597-f002){ref-type="fig"} reports the interaction plots obtained with observed-predicted pH values, lactic acid concentration levels and sakacin A production obtained in trials performed without (i) or with 0.5 g/L (ii) and 1 g/L (iii) arginine.

The lowest pH levels were always associated with the highest YE concentration (blue line), while a low influence of ME was observed. As expected, higher pH levels were evidenced in trials with arginine, confirming the activation of the ADI pathway.

Both, lactic acid and sakacin A productions, were at their lowest levels when no YE and ME were added, i.e., when microbial growth was limited. A direct correlation was evident between the concentration of these two ingredients and lactic acid production, YE being more influent than ME on *L. sakei* growth and bacteriocin production. This ingredient, due to the presence of amino acids and peptides, has already been reported to promote LAB cell growth \[[@B4-biomolecules-10-00597]\].

The analysis of free amino acids was also performed ([Table 5](#biomolecules-10-00597-t005){ref-type="table"}): Trials containing 0.5 g/L arginine ([Table 3](#biomolecules-10-00597-t003){ref-type="table"}, Run 9) and the correspondent, without ([Table 3](#biomolecules-10-00597-t003){ref-type="table"}, Run 27) evidence that arginine was totally depleted in both samples, as expected, and ornithine steeply increased. Cysteine and glutamine were absent either at t0 and at the end of incubation in both the formulation without or with arginine.

Serine was found to sharply decrease during cell growth of about −98, and −85%, respectively in samples without and with arginine. Serine decrease during *L. sakei* growth may indicate the possible existence of metabolic routes aimed to produce energy; serine conversion into pyruvate has been described in *P. pentosaceus* due to the action of a serine dehydratase \[[@B36-biomolecules-10-00597]\].

McLeod et al. \[[@B37-biomolecules-10-00597]\] observed a drastic utilization of serine and asparagine in *L. sakei* strains grown under glucose limiting conditions. Montanari et al. \[[@B38-biomolecules-10-00597]\] calculated a 30% decrease of the serine + asparagine concentration in *L. sakei* cultured in MRS medium; here, a 55% decrease of this amino acid association was evidenced with no significant difference related to the presence of arginine.

The optimization approach suggested by the software (desirability higher than 0.800) to maximize sakacin A and lactic acid production while minimizing pH, resulted in 7 medium formulations, reported in [Table 6](#biomolecules-10-00597-t006){ref-type="table"} together with their respective formulation cost (€/L), sakacin A production yield (AU/L) and production cost (€/10^6^ AU).

Keeping in mind the final goal of the present work, the most convenient SAK formulation was found composed by ME at 4 g/L, YE at 8 g/L and no arginine, having a formulation cost of around 1.53 €/L and an estimated sakacin A cost of around 5.67 €/10^6^ AU. Compared with the values obtained in MRS (5.40 €/L, 18.00 €/10^6^ AU), a 70% decrease in the production costs was reached in this study. Mapelli et al. \[[@B27-biomolecules-10-00597]\] employing the non-optimized SAK formulation, resulted in 2.33 €/L and 8.06 €/10^6^ AU, around 30% higher. Trinetta et al. \[[@B30-biomolecules-10-00597]\] reported, for sakacin A, higher production costs (2.9 €/L), 50% more expensive medium containing bacto peptone, meat peptone, cheese whey, yeast autolysate, glucose and calcium carbonate.

Even if prices are calculated on the basis of ingredients purchased in lab-scale mass, difference in cost among the selected formulations still can be compared to identify the most convenient choice. Note also, that when up-scaling the quantity to be purchased, the cost will be reduced accordingly: so far, starting from the formulation here reported, the production cost of sakacin A is likely to be lower than that reported here. Taking into account that the limited use of bacteriocins in the production of antimicrobial materials for food packaging solutions is mainly due to their high production cost, the obtained reduction may widen the range of applications of these molecules as antilisterial food-grade compounds.

Mapelli et al. \[[@B29-biomolecules-10-00597]\] set-up an antilisterial packaging material, based on sakacin A incorporated in cellulose nano-fibers (CNF), and demonstrated its antimicrobial activity on smoked salmon fillets intentionally inoculated with *Listeria*. The active material was prepared at a sakacin A concentration of around 50 AU/cm^2^ employing a culture medium with a formulation cost of around 8.06 €/10^6^ AU; at the reported conditions, production cost of the active mat in terms of sakacin A content resulted around 4.03 €/m^2^. With the here proposed new culture medium formulated with liquid CWP, bacteriocin production cost can be reduced from 2.33 to 1.53 €/L (5.67 €/10^6^ AU), with a cost reduction of the active material up to 2.84 €/m^2^ (−30%).

4. Conclusions {#sec4-biomolecules-10-00597}
==============

The present paper contributes to CWP valorization by applying the circular economy concepts expressed by de la Caba et al. \[[@B29-biomolecules-10-00597]\]. This required a food industry by-product to produce antimicrobials for food preservation. This residue has been used to optimize a culture medium formulation suitable for the production of sakacin A, bacteriocin with a specific antilisterial activity obtained by *Lactobacillus sakei*. The six best formulations identified as effective in maximizing sakacin A production yield, significantly differed for their bacteriocin production cost. From an economic perspective the culture medium did not always give the highest bacteriocin production titre has the cheapest formulation. The research highlighted up to 70% decrease of sakacin A production costs can be reached compared to what obtainable in the MRS reference medium, and even in the other already published papers. This reduction will pave the way for the possibility of extending the use of sakacin A as natural antimicrobial in the production of active packaging solutions to face the risk of *Listeria monocytogenes* outbreaks in food items.
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![*L. sakei* DSM 6333 growth in MRS (left) and SAK (right) formulation at 26 °C. Different curves correspond to different percentage of inoculum (*v*/*v*), from 0.1% (light grey) to 5% (black).](biomolecules-10-00597-g001){#biomolecules-10-00597-f001}

![Interactions plots: responses related to culture pH (first row), lactic acid (second row) and sakacin A production (third row, expressed as inhibition halo vs. *Listeria*) in supernatants of *L. sakei*. Factors: A-ME (Meat Extract) at 0-4-8 g/L on X-axis; B-YE (Yeast Extract) at 0 g/L (red)--4 g/L (green)--8 g/L (blue); results obtained without arginine (first column), with arginine set at 0.5 g/L (second column) and 1 g/L (third column).](biomolecules-10-00597-g002){#biomolecules-10-00597-f002}

biomolecules-10-00597-t001_Table 1

###### 

Ingredients cost of MRS (benchmark) and SAK culture media (lab scale).

  Medium   Ingredient      Cost €/Kg   g/L     €/L     Share of SAK Cost (%)
  -------- --------------- ----------- ------- ------- -----------------------
  MRS      As purchased    104         52.2    5.40    \-
  SAK      Yeast Extract   60          8       0.48    21
           Meat Extract    149         8       1.19    52
           Arginine        415         0.5     0.20    9
           Tween-80        83.7        0.5     0.04    2
           Vitamin mix     0.37 €/mL   1 mL    0.37    16
           CWP             0.015 €/L   1 L     0.015   1
                                       TOTAL   2.30    100

biomolecules-10-00597-t002_Table 2

###### 

*L. sakei* growth curves fitting parameters in MRS and SAK media differently inoculated (from 0.1 to 5% *v*/*v*).

  ----------------------------------------------------------------------------------------------------------------------------------------------
  Inoculum\      0.1% (*v*/*v*)\   0.5% (*v*/*v*)\   1% (*v*/*v*)\   5% (*v*/*v*)\                                                   
  Medium         MRS SAK           MRS SAK           MRS SAK         MRS SAK                                                         
  -------------- ----------------- ----------------- --------------- --------------- ----------- ----------- ----------- ----------- -----------
  Lag phase\     mean              3.267 ^A^         5.266 ^B^       2.581 ^A^       3.794 ^B^   1.854 ^A^   2.895 ^B^   0.010 ^A^   1.839 ^B^
  (h)                                                                                                                                

  std. dev       0.009             0.109             0.063           0.111           0.083       0.061       0.010       0.067       

  Growth rate\   mean              0.200 ^A^         0.255 ^B^       0.219 ^A^       0.239 ^B^   0.237 ^A^   0.250 ^B^   0.241 ^A^   0.306 ^B^
  (OD/h)                                                                                                                             

  std. dev       0.009             0.004             0.007           0.002           0.009       0.002       0.014       0.009       

  Final Value\   mean              1.517 ^B^         1.459 ^A^       1.550 ^B^       1.452 ^A^   1.558 ^B^   1.496 ^A^   1.613 ^B^   1.534 ^A^
  (OD)                                                                                                                               

  std. dev       0.031             0.013             0.005           0.063           0.016       0.018       0.019       0.005       

  Sakacin A      AU/mL             267               233             267             233         267         267         300         333

                 Time (h)          16                16              16              16          12          12          8           8
  ----------------------------------------------------------------------------------------------------------------------------------------------

Values with different superscripts uppercase (^A^, ^B^) letter within the same raw are significantly different (*p* \< 0.05).

biomolecules-10-00597-t003_Table 3

###### 

Arrangement of the experimental design performed with *L. sakei* grown at 26 °C for 16 h (ME-Meat Extract, YE-Yeast Extract, Arg-arginine) and observed responses: Culture pH, lactic acid concentration (g/L) and sakacin A production (expressed as inhibition halo-mm-vs. *L. innocua*).

  ------------------------------------------------------------------------------------------------------------
  Trial   A-ME\   B-YE\   C-Arg\   Culture pH   Lactic Acid (g/L)   Sakacin A Prod. (mm)                 
          (g/L)   (g/L)   (g/L)                                                                          
  ------- ------- ------- -------- ------------ ------------------- ---------------------- ------ ------ -----
  *1*     0       0       0.5      6.32         0.04                0.01                   0.00   0.0    0.0

  *2*     0       4       0.5      5.15         0.07                1.35                   0.00   7.0    0.0

  *3*     0       8       0.5      5.02         0.09                1.84                   0.21   9.5    0.7

  *4*     4       0       0.5      6.18         0.02                0.68                   0.00   8.0    0.0

  *5*     4       4       0.5      5.64         0.00                1.56                   0.01   9.5    0.7

  *6*     4       8       0.5      5.14         0.16                2.35                   0.13   11.5   0.7

  *7*     8       0       0.5      6.18         0.04                0.98                   0.01   10.0   0.0

  *8*     8       4       0.5      5.72         0.00                1.81                   0.05   11.5   0.7

  *9*     8       8       0.5      5.35         0.03                2.59                   0.02   13.0   0.0

  *10*    0       0       1        6.49         0.02                0.01                   0.00   0.0    0.0

  *11*    0       4       1        5.23         0.19                1.20                   0.18   3.0    0.0

  *12*    0       8       1        5.16         0.11                1.70                   0.33   8.0    0.0

  *13*    4       0       1        6.45         0.05                0.80                   0.01   7.5    0.7

  *14*    4       4       1        5.97         0.10                1.57                   0.05   10.0   0.0

  *15*    4       8       1        5.44         0.18                2.47                   0.04   11.5   0.7

  *16*    8       0       1        6.49         0.04                1.03                   0.06   10.0   0.0

  *17*    8       4       1        6.06         0.01                1.88                   0.04   11.0   0.0

  *18*    8       8       1        5.63         0.15                2.66                   0.13   12.0   0.0

  *19*    0       0       0        6.10         0.01                0.03                   0.01   0.0    0.0

  *20*    0       4       0        4.99         0.06                1.33                   0.10   7.0    0.0

  *21*    0       8       0        4.85         0.05                1.93                   0.00   9.5    0.7

  *22*    4       0       0        5.54         0.07                0.69                   0.06   7.5    0.7

  *23*    4       4       0        5.13         0.11                1.45                   0.07   9.0    0.0

  *24*    4       8       0        4.90         0.07                2.11                   0.26   10.5   0.7

  *25*    8       0       0        5.63         0.04                0.90                   0.06   8.5    0.7

  *26*    8       4       0        5.24         0.04                1.74                   0.06   10.5   0.7

  *27*    8       8       0        5.05         0.04                2.44                   0.07   11.5   0.7

  MRS     \-      \-      \-       4.45         0.10                5.62                   0.18   13.0   0.7
  ------------------------------------------------------------------------------------------------------------
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###### 

ANOVA response, effect estimates, models adaptation goodness as well as variability and noise ratio for each of the observed responses (pH, lactic acid and sakacin A production) of the experimental design reported in [Table 3](#biomolecules-10-00597-t003){ref-type="table"} (α-out: 0.05).

  ------------------------------------------------------------------------------
  Parameter        pH               Lactic Acid                 Sakacin A\
                                                                Production
  ---------------- ---------------- --------------------------- ----------------
  Model            *p* \< 0.0001\   *p* \< 0.0001 Square root   *p* \< 0.0001\
                   Linear                                       Linear

  A-ME             *p* \< 0.0001    *p* \< 0.0001               *p* \< 0.0001

  B-YE             *p* \< 0.0001    *p* \< 0.0001               *p* \< 0.0001

  C-Arg            *p* \< 0.0001    ns \*                       *p* \< 0.0001

  AB               *p* \< 0.0001    *p* \< 0.0001               *p* \< 0.0001

  AC               *p* \< 0.0001    ns                          *p* \< 0.0001

  BC               *p* 0.0093       ns                          *p* 0.0040

  ABC              ns               ns                          *p* 0.0008

  Lack of fit      0.457 ns         0.1066 ns                   \- (Saturated)

  Model std. dev   0.086            0.048                       0.047

  mean             5.59             1.13                        0.85

  C.V.%            1.53             4.25                        5.56

  R^2^             0.9828           0.9894                      0.9916

  Adj R^2^         0.9740           0.9875                      0.9834

  Pred R^2^        0.9591           0.9847                      0.9663

  Adeq precision   32.449           75.839                      39.000
  ------------------------------------------------------------------------------

\* ns: not significant, *p* value \> 0.0500.

biomolecules-10-00597-t005_Table 5

###### 

Free amino acid concentration (mg/L) at t0 and 16 h incubation and percent variation in *L. sakei* grown cultures in SAK medium without or with L-arginine addition (0.5 g/L). Data reported as means, CV in the range 7--12%.

  Amino Acid      YE 8-ME 8-ARG 0   YE 8-ME 8-ARG 0.5                          
  --------------- ----------------- ------------------- ------ ------- ------- ------
  Alanine         171.0             183.8               7      169.3   183.4   8
  Arginine        194.0             0.0                 −100   526.0   0.0     −100
  Asparagine      78.0              63.6                −18    76.5    56.7    −26
  Aspartate       138.4             127.8               −8     137.5   131.9   −4
  Citrulline      26.5              24.1                −9     25.8    24.9    −3
  Cysteine        0.0               0.0                 0      0.0     0.0     0
  GABA            10.2              10.4                2      10.1    10.5    4
  Glutamine       0.0               0.0                 0      0.0     0.0     0
  Glutamate       402.6             429.9               7      392.3   423.6   8
  Glycine         70.0              89.0                27     69.1    89.9    30
  Histidine       44.2              49.3                12     45.8    50.6    10
  Isoleucine      131.7             175.4               33     129.9   175.9   35
  Leucine         254.5             296.0               16     251.2   293.5   17
  Lysine          189.5             216.8               14     185.7   214.9   16
  Methionine      50.2              51.9                3      48.0    53.0    10
  Ornithine       15.8              142.4               802    15.1    233.8   1449
  Phenilalanine   180.3             201.1               12     180.6   202.4   12
  Proline         52.8              70.2                33     52.0    71.3    37
  Serine          98.4              11.4                −88    94.5    5.2     −95
  Threonine       89.4              124.9               40     88.7    117.9   33
  Tryptophan      40.1              54.1                35     39.6    54.4    37
  Tyrosine        95.7              141.4               48     138.8   180.7   30
  Valine          176.6             221.1               25     177.2   220.7   25
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###### 

Media formulations calculated by the optimization process (Design Expert^®^, desirability \>0.800), maximizing lactic acid and sakacin A production: estimated cost of formulation (€/L), sakacin A production yield (10^6^ AU/L) and cost (€/10^6^ AU) reported and compared with those obtained with MRS (benchmark).

  -----------------------------------------------------------------------------------------------------------------------------------------
  Medium    ME\     YE\    Arg\    pH     Lactic Acid (g/L)   Desirability   Medium Cost (€/L)   Sak. A Yield (10^6^ AU/L)   Sak. A Cost\
            (g/L)   (g/L   (g/L)                                                                                             (€/10^6^ AU)
  --------- ------- ------ ------- ------ ------------------- -------------- ------------------- --------------------------- --------------
  1 (SAK)   8       8      0.5     5.35   2.56                0.907          2.30                0.289                       7.96

  2         8       8      0       5.09   2.56                0.907          2.13                0.242                       8.80

  3         4       8      0       4.84   2.30                0.878          1.53                0.270                       5.67

  4         4       8      0.5     5.16   2.30                0.870          1.73                0.278                       6.22

  5         0       8      0.5     4.98   1.82                0.825          1.14                0.190                       7.37

  6         4       8      1       5.47   2.30                0.823          1.93                0.233                       8.28

  7         8       8      1       5.65   2.56                0.819          2.53                0.233                       10.86

  MRS       \-      \-     \-      4.45   5.62                \-             5.40                0.300                       18.00
  -----------------------------------------------------------------------------------------------------------------------------------------
